DOJ plans to reschedule marijuana as a lower-risk drug

The Biden administration plans to reclassify marijuana as a lower-risk substance, according to a person familiar with the matter. The move acknowledges the medical benefits of the drug and has implications for cannabis-related research and the industry. The US Department of Justice is expected to recommend that marijuana be rescheduled as a Schedule III controlled substance, along with prescription drugs like ketamine and Tylenol with codeine. The reclassification has been hailed by lawmakers from both parties. Currently categorized as a Schedule I substance, marijuana has faced strict restrictions for over 50 years.